Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-24,081
Closed -$6.77M 4326
2018
Q1
$6.59M Buy
+24,081
New +$7.47M 0.03% 656
2017
Q2
Sell
-6,202
Closed -$1.64M 4537
2017
Q1
$1.7M Sell
6,202
-53,385
-90% -$15.1M 0.01% 1275
2016
Q4
$16.9M Buy
59,587
+31,982
+116% +$9.48M 0.12% 168
2016
Q3
$8.64M Sell
27,605
-39,389
-59% -$11.7M 0.06% 412
2016
Q2
$16.2M Buy
66,994
+40,461
+152% +$10.7M 0.12% 166
2016
Q1
$6.91M Sell
26,533
-49,440
-65% -$13.1M 0.06% 468
2015
Q4
$23.3M Sell
75,973
-23,648
-24% -$6.8M 0.16% 120
2015
Q3
$29.1M Buy
99,621
+94,709
+1,928% +$31.3M 0.15% 124
2015
Q2
$1.98M Sell
4,912
-3,210
-40% -$1.29M 0.01% 1479
2015
Q1
$3.43M Sell
8,122
-92,148
-92% -$36.3M 0.03% 903
2014
Q4
$34M Buy
100,270
+3,456
+4% +$1.12M 0.26% 49
2014
Q3
$32M Sell
96,814
-2,014
-2% -$664K 0.25% 50
2014
Q2
$31.2M Buy
98,828
+18,373
+23% +$5.53M 0.3% 34
2014
Q1
$24.6M Buy
80,455
+53,943
+203% +$17.1M 0.21% 55
2013
Q4
$7.41M Sell
26,512
-76,782
-74% -$19.9M 0.05% 475
2013
Q3
$12.4M Buy
103,294
+70,525
+215% +$15.8M 0.09% 252
2013
Q2
$7.05K Buy
+32,769
New +$7M 0.03% 509

Other funds holding BIIB

PEAK6 Group's BIIB Position: Q2 2018 in Review

PEAK6 Group sold out of Biogen (BIIB) in Q2 2018, closing a stake of 24,081 shares — an estimated $6.77M sold.

PEAK6 Group first reported a position in BIIB in Q2 2013 and held it in 17 quarters. The position peaked at $34M in Q4 2014. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • PEAK6 Group reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 24,081 Biogen shares in Q2 2018, an estimated $6.77M.
  • PEAK6 Group first reported a position in Biogen in Q2 2013 and held it in 17 quarters.
  • PEAK6 Group's Biogen position peaked at $34M in Q4 2014.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.